- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 99-113 of
195 results
1016 Exhibit: Merke Congenital Adrenal Hyperplasia
Document
PGR2022-00025, No. 1016-15 Exhibit - Merke Congenital Adrenal Hyperplasia (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1024 Exhibit: Merke Congenital Adrenal Hyperplasia Due to 21 Hydroxylase Deficie...
Document
PGR2022-00025, No. 1024-23 Exhibit - Merke Congenital Adrenal Hyperplasia Due to 21 Hydroxylase Deficiency, (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1011 Exhibit: Spruce Biosciences Presents Phase 1 and 2 Data for Tildacerfont in A...
Document
PGR2022-00025, No. 1011-10 Exhibit - Spruce Biosciences Presents Phase 1 and 2 Data for Tildacerfont in Adults with Congenital Adrenal Hyperplasia from Endocrine Societys 2021 Annual Me...
|
|
Cite Document
1038 Exhibit: Fuqua Duration of Suppression of Adrenal Steroids after Glucocortico...
Document
PGR2022-00025, No. 1038-37 Exhibit - Fuqua Duration of Suppression of Adrenal Steroids after Glucocorticoid Administration (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1034 Exhibit: Shargel Applied Biopharmaceutics Pharmacokinetics 6th ed 2012
Document
PGR2022-00025, No. 1034-33 Exhibit - Shargel Applied Biopharmaceutics Pharmacokinetics 6th ed 2012 (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1023 Exhibit: Microparticles Formulation as a Targeting Drug Delivery System, J Na...
Document
PGR2022-00025, No. 1023-22 Exhibit - Microparticles Formulation as a Targeting Drug Delivery System, J Nanomed Res (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1004 Exhibit: US Provisional Application Serial No 62545,406
Document
PGR2022-00025, No. 1004-4 Exhibit - US Provisional Application Serial No 62545,406 (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1036 Exhibit: US Patent No 10,849,908 to Alexis Howerton, et al
Document
PGR2022-00025, No. 1036-35 Exhibit - US Patent No 10,849,908 to Alexis Howerton, et al (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1022 Exhibit: Merke Future Directions in the Study and Management of Congenital ...
Document
PGR2022-00025, No. 1022-21 Exhibit - Merke Future Directions in the Study and Management of Congenital Adrenal Hyperplasia due to 21 Hydroxylase Deficiency (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1029 Exhibit: Williams, Corticotropin Releasing Factor 1 Receptor Antagonists A Pa...
Document
PGR2022-00025, No. 1029-28 Exhibit - Williams, Corticotropin Releasing Factor 1 Receptor Antagonists A Patent Review (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
2001 Exhibit: EX2001 Anthenelli
Document
PGR2022-00025, No. 2001-41 Exhibit - EX2001 Anthenelli (P.T.A.B. Jun. 17, 2022)
|
|
Cite Document
2005 Exhibit: EX2005 Benedetti
Document
PGR2022-00025, No. 2005-45 Exhibit - EX2005 Benedetti (P.T.A.B. Jun. 17, 2022)
|
|
Cite Document
1009 Exhibit: Auchus Crinecerfont Lowers Elevated Hormone Markers in Adults Wit...
Document
PGR2022-00025, No. 1009-8 Exhibit - Auchus Crinecerfont Lowers Elevated Hormone Markers in Adults With 21 Hydroxylase Deficiency Congenital Adrenal Hyperplasia (P.T.A.B. Feb. 18, 2022...
|
|
Cite Document
2002 Exhibit: EX2002 Hamilton
Document
PGR2022-00025, No. 2002-42 Exhibit - EX2002 Hamilton (P.T.A.B. Jun. 17, 2022)
|
|
Cite Document
1002 Exhibit: US Prosecution History of the 201 Patent
Document
PGR2022-00025, No. 1002-2 Exhibit - US Prosecution History of the 201 Patent (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
